Addition of SBRT and Outcomes in Borderline Resectable Pancreatic Cancer Patients Having Suboptimal Response to Neoadjuvant Chemotherapy
Year: 2024
Type: article
Authors: R. Engineer, P. Pathare, M. Bhandare, R. Krishnatry, S. Gudi, V. Ostwal, A. Ramaswamy, S. Shrikhande
Institutions: Homi Bhabha National Institute, Tata Memorial Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4402909409
